Register now – Nov. 19, 2025: Regulatory compliance and recent policy changes at the federal and state levels relevant to hospital laboratory outreach programs.

Launch or refresh your lab newsletter with five key steps to engage, inform, and build stronger connections with your audience.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, and William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, discuss recent news about the use of artificial intelligence (AI) tools in healthcare.

The quest to create a test pinpointing the source of the rare, testicular cancer-associated illness successfully concluded in the summer of 2021.

In a recent Wall Street Journal article, the director of Mayo Clinic’s Infectious Diseases Serology Laboratory, Elitza Theel, Ph.D., was among a group of experts discussing the value of COVID-19 antibody testing.

Starting December 7, you will notice enhancements to MayoClinicLabs.com. We are building a better website for you, our clients, to ensure the best experience possible. We’re moving toward a simpler, more intuitive and customized experience, making it easier to do business with us. 

Topic's Include: Mayo Clinic Q&A podcast: Boosters reduce vulnerability to COVID-19 variants, what Mayo experts know about the omicron variant, and mental health and the holidays: Resilience.

While Gregor Heinrich never could have imagined that testicular cancer was related to his problems with his vision and gait, learning he was positive for KLHL11 protein biomarkers meant he could receive treatment for both the cancer and the illness behind it.

Today's Highlights Include: What are omicron variant symptoms? Everything to know about the latest COVID-19 strain, it’s flu season, and here’s why you should get your flu shot this winter, and will the vaccines stop Omicron? Scientists are racing to find out.

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., and Thomas Grys, Ph.D., Associate Professor of Laboratory Medicine and Pathology in the Mayo Clinic College of Medicine and Science and co-director of Microbiology at Mayo Clinic’s Arizona campus, discuss valley fever testing and the importance of clinical context.

This week on "Answers From the Lab," William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. As the omicron variant of SARS-CoV-2 gains attention and generates concern, Dr. Morice and Dr. Pritt discuss what’s being done to learn more about this new variant and the effects it could have on the fight against COVID-19.

The following list includes updates posted to mayocliniclabs.com during the month of November.

Even though the area he supervises is extremely busy, and patients typically spend only a short amount of time there, Todd Juen strives to foster an environment where no one is treated like a number and everyone feels well cared for — patients and staff members alike.

This week’s research roundup features: Tumor junction burden and antigen presentation as predictors of survival in mesothelioma treated with immune checkpoint inhibitors.

Topic's Include: Preventing, treating COVID-19 infection, Mayo Clinic rolls out COVID-19 booster vaccinations for all adults, and mental health and the holidays: Grieving.